Luo Man, Fu Dongdong, Zhu Huaqun, Li Yuan, Ye Hua
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Department of Rheumatology and Immunology, Central Hospital of Suining, Sichuan, China.
Clin Rheumatol. 2025 Jun;44(6):2413-2419. doi: 10.1007/s10067-025-07466-0. Epub 2025 May 6.
To analyze the clinical characteristics of malignant lymphoma that closely resembles IgG4-related disease (IgG4-RD).
This study retrospectively analysis involving 31 patients who were lymphoma mimicking, IgG4-RD and 50 contemporaneous IgG4-RD patients serving as controls. Lymphoma mimicking IgG4-RD was defined as presenting with masses in the typical sites of IgG4-RD, with or without elevated serum IgG4 levels, and ultimately confirmed to be lymphoma. The clinical data, including the extent of lymph node involvement, maximum diameter of lymph nodes, systemic symptoms, and laboratory parameters were assessed. Student's t-test, the Mann-Whitney test, and the chi-squared test were used to compare the two groups.
Fever emerged as a distinctive feature in lymphoma patients. Compared to IgG4-RD, lymphoma patients exhibited a greater extent of lymph node involvement (p < 0.001), larger maximum diameters of lymph nodes (p = 0.007), and higher frequency of enlargement in supraclavicular (41.9% vs 10.0%; p = 0.001), armpit (45.2% vs 16.0%; p = 0.004), retroperitoneal (70.9% vs 10.0%; p < 0.001), and groin lymph nodes (41.9% vs 8.0%; p < 0.001). In contrast, IgG4-RD patients were more likely to show involvement of submandibular gland (58.0% vs 29.0%; p = 0.015) and pancreatic (44.0% vs 9.7%; p = 0.001). Additionally, lymphoma patients presented with higher levels of erythrocyte sedimentation rate (ESR) (p = 0.010), C-reactive protein (CRP) (p < 0.001), and lactate dehydrogenase (LDH) (p = 0.002), along with a higher prevalence of anemia (35.5% vs 4.0%; p < 0.001) and lower albumin levels (p = 0.039), while IgG4-RD patients had higher IgG4/IgG ratio (p < 0.001) and lower complement 3 (C3) (p = 0.009) levels than lymphoma patients.
Although patients with malignant lymphoma and IgG4-RD share some overlapping presentations, they differ significantly in some distinct features, including fever, pattern of lymph node and organ involvement distribution, and some laboratory parameters. Key Points • IgG4-related disease (IgG4-RD) is an immune-mediated disorder characterized by elevated serum IgG4 levels, presenting lymphadenopathy and tumor-like sclerosing lesions in extranodal sites. • Lymphoma, a malignancy that originates from lymphocytes, can present with a variety of clinical manifestations, including painless swelling of lymph nodes and enlargement of different organs. • While patients with malignant lymphoma and IgG4-RD share certain overlapping clinical presentations, they exhibit significant differences in distinct features, including fever, patterns of lymph node and organ involvement, and various laboratory parameters.
分析酷似IgG4相关疾病(IgG4-RD)的恶性淋巴瘤的临床特征。
本研究回顾性分析了31例疑似淋巴瘤的IgG4-RD患者,并将50例同期IgG4-RD患者作为对照。酷似IgG4-RD的淋巴瘤定义为在IgG4-RD的典型部位出现肿块,血清IgG4水平可升高或不升高,最终确诊为淋巴瘤。评估临床资料,包括淋巴结受累范围、淋巴结最大直径、全身症状和实验室参数。采用Student's t检验、Mann-Whitney检验和卡方检验对两组进行比较。
发热是淋巴瘤患者的一个显著特征。与IgG4-RD相比,淋巴瘤患者的淋巴结受累范围更大(p < 0.001),淋巴结最大直径更大(p = 0.007),锁骨上淋巴结肿大的频率更高(41.9%对10.0%;p = 0.001)、腋窝淋巴结肿大的频率更高(45.2%对16.0%;p = 0.004)、腹膜后淋巴结肿大的频率更高(70.9%对10.0%;p < 0.001)以及腹股沟淋巴结肿大的频率更高(41.9%对8.0%;p < 0.001)。相比之下,IgG4-RD患者更易出现颌下腺受累(58.0%对29.0%;p = 0.015)和胰腺受累(44.0%对9.7%;p = 0.001)。此外,淋巴瘤患者的红细胞沉降率(ESR)(p = 0.010)、C反应蛋白(CRP)(p < 0.001)和乳酸脱氢酶(LDH)水平更高(p = 0.002),贫血患病率更高(三十五点儿五%对4.0%;p < 0.001),白蛋白水平更低(p = 0.039),而IgG4-RD患者的IgG4/IgG比值更高(p < 0.001),补体3(C3)水平低于淋巴瘤患者(p = 0.009)。
尽管恶性淋巴瘤患者和IgG4-RD患者有一些重叠的表现,但它们在一些明显特征上有显著差异,包括发热、淋巴结和器官受累分布模式以及一些实验室参数。要点•IgG4相关疾病(IgG4-RD)是一种免疫介导的疾病,其特征是血清IgG4水平升高,表现为淋巴结病和结外部位的肿瘤样硬化性病变。•淋巴瘤是一种起源于淋巴细胞的恶性肿瘤,可表现出多种临床表现,包括淋巴结无痛性肿大和不同器官肿大。•虽然恶性淋巴瘤患者和IgG4-RD患者有某些重叠的临床表现,但它们在明显特征上有显著差异,包括发热、淋巴结和器官受累模式以及各种实验室参数。